Building the biopharma company of the future

Find Out More

Developing New Categories of Medicine

Our goal is to improve and extend the lives of patients through the development of new categories of medicine

Explore Our Pipeline

Exploring the Brain Immune Gut (BIG) Axis

Focused on the crosstalk and biological processes associated with the brain-immune-gut interface

See Our Science

Giving Life to Science™

Our goal is to improve and extend the lives of patients

Moving Medicine Forward

Meet Our Team

Discovery Reinvented

See Our Case Studies
Publications
Publications -2017-09-19
Gamma Delta T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation

CD4(+) T regulatory cells (T(regs)), which express the Foxp3 transcription factor, play a critical role in the maintenance of immune homeostasis. Here, we show that in mice, T(regs) were most abundant in the colonic mucosa.

Full Article

Publications -2017-09-19
The Gut’s Clostridium Cocktail

Specific components of the microbiota—the microorganisms that normally colonize the body—can affect disease progression in mouse models of arthritis, central nervous system inflammation, diabetes, intestinal inflammation, and obesity.

Full Article
Publications -2017-06-01
Video game training enhances cognitive control in older adults

Cognitive controlis defined by a set of neural processes that allow us to interact with our complex environment in a goal-directed manner.

FULL ARTICLE

Press releases
2018-04-16
PureTech Health Announces Annual Results for Year Ended 31 December 2017

CONTINUE

Media Coverage
2018-04-10
PureTech Health spin-outs Akili and Sonde Health announce new international patents

This week has spurred some major patent announcements from digital health companies Akili Interactive and Sonde Health, which are both affiliated with PureTech Health, a cross disciplinary biopharma company.

Full Article

Press releases
2018-04-10
PureTech Health Affiliates Expand Digital Medicine IP Portfolios with Key Patent Issuances

US and international patent grants for Akili and Sonde technology platforms highlight PureTech’s foundational leadership position in the growing field of digital medicine

PureTech Health plc (LSE: PRTC) (“PureTech Health”), an advanced, clinical-stage biopharmaceutical company, announced today that its affiliates, Akili Interactive Labs, Inc. and Sonde Health, Inc., have been granted key patents broadly covering their respective proprietary technology platforms.

Continue